Ashkan Ertefaie

Ashkan Ertefaie

Auto-generated profile, based on publicly available information

Ashkan Ertefaie

Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 February 2017 in Pharmacoepidemiology and Drug Safety
Verified
Journal Article
Closed access
PDF file
AEAshkan Ertefaie
Ashkan Ertefaie
DSDylan S. Small
Dylan S. Small
JFJames H. Flory
James H. Flory
SHSean Hennessy
Sean Hennessy

8 December 2017 in Journal of Causal Inference
Verified
Journal Article
Open access
PDF file
AEAshkan Ertefaie
Ashkan Ertefaie
MAMasoud Asgharian
Masoud Asgharian
DSDavid A. Stephens
David A. Stephens
In the causal adjustment setting, variable selection techniques based only on the outcome or only on the treatment allocation model can result in the omission of confounders and hence may lead to bias, or the inclusion of spurious variables and hence cause variance inflation, in estimation of the treatment effect. We propose a variable selection method using a penalized objective function that is based on both the outcome and treatment assignment models. The proposed method facilitates confounder selection in high-dimensional settings. We show that under some mild conditions our method attains the oracle property. The selected variables are used to form a doubly robust regression estimator of the treatment effect. Using the proposed method we analyze a set of data on economic growth and study the effect of life expectancy as a measure of population health on the average growth rate of gross domestic product per capita.

14 December 2021 in Journal of the Royal Statistical Society Series B: Statistical Methodology
Verified
Journal Article
Open access
PDF file
QZQingyuan Zhao
Qingyuan Zhao
DSDylan Small
Dylan Small
AEAshkan Ertefaie
Ashkan Ertefaie
Effect modification occurs when the effect of the treatment on an outcome varies according to the level of other covariates and often has important implications in decision-making. When there are tens or hundreds of covariates, it becomes necessary to use the observed data to select a simpler model for effect modification and then make valid statistical inference. We propose a two-stage procedure to solve this problem. First, we use Robinson's transformation to decouple the nuisance parameters from the treatment effect of interest and use machine learning algorithms to estimate the nuisance parameters. Next, after plugging in the estimates of the nuisance parameters, we use the lasso to choose a low-complexity model for effect modification. Compared to a full model consisting of all the covariates, the selected model is much more interpretable. Compared to the univariate subgroup analyses, the selected model greatly reduces the number of false discoveries. We show that the conditional selective inference for the selected model is asymptotically valid given the rate assumptions in classical semiparametric regression. Extensive simulation studies are conducted to verify the asymptotic results and an epidemiological application is used to demonstrate the method.

28 December 2016 in Addiction
Verified
Journal Article
Closed access
PDF file
INInbal Nahum‐Shani
Inbal Nahum‐Shani
AEAshkan Ertefaie
Ashkan Ertefaie
XLXi (Lucy) Lu
Xi (Lucy) Lu
KLKevin G. Lynch
Kevin G. Lynch
JMJames R. McKay
James R. McKay
DADaniel Almirall
Daniel Almirall

26 May 2022 in Suicide and Life-Threatening Behavior
Verified
Journal Article
Open access
APAnthony R. Pisani
Anthony R. Pisani
MGMadelyn Gould
Madelyn Gould
CGCarlos Gallo
Carlos Gallo
AEAshkan Ertefaie
Ashkan Ertefaie
CKCaroline Kelberman
Caroline Kelberman
SGShannon Green
Shannon Green
Objective: Text‐based crisis services are increasingly prominent, with inclusion in the national 988 crisis number launching in 2022. Yet little is known about who uses them. This study seeks to understand the population served by Crisis Text Line (CTL), the largest crisis text service in the United States.Methods: Secondary data analysis was conducted on de‐identified Crisis Counselor reports, texter post‐conversation survey responses, and anonymized text conversation data from 85,877 texters who contacted CTL during a 12‐month period. We examined Crisis Counselor's ratings of suicide ideation severity, texters' reports of race, gender, sexual orientation, recent mental health symptoms, and additional sources of help, and logs of frequency of contact.Results: 76% of texters were under 25. 79% were female. 48% identified as other than heterosexual/straight. 64% had only one conversation. 79% were above the clinical cutoff for depression and 80% for anxiety, while 23% had thoughts of suicide. 23% received help from a doctor or therapist, and 28% received help only from CTL.Conclusions: CTL reaches a highly distressed, young, mostly female population, including typically underserved minorities and a substantial percentage of individuals who do not receive help elsewhere. These findings support the decision to include texting in the forthcoming national 988 implementation.

8 June 2020 in Journal of the American Statistical Association
Verified
Journal Article
Closed access
AEAshkan Ertefaie
Ashkan Ertefaie
JMJames R. McKay
James R. McKay
DODavid Oslin
David Oslin
RSRobert L. Strawderman
Robert L. Strawderman
Abstract–Q-learning is a regression-based approach that is widely used to formalize the development of an optimal dynamic treatment strategy. Finite dimensional working models are typically used to estimate certain nuisance parameters, and misspecification of these working models can result in residual confounding and/or efficiency loss. We propose a robust Q-learning approach which allows estimating such nuisance parameters using data-adaptive techniques. We study the asymptotic behavior of our estimators and provide simulation studies that highlight the need for and usefulness of the proposed method in practice. We use the data from the “Extending Treatment Effectiveness of Naltrexone” multistage randomized trial to illustrate our proposed methods. Supplementary materials for this article are available online.